Efficacy and safety of sitagliptin as a third therapeutic agent in the treatment of type 2 diabetes mellitus

2014 
Abstract Background: Information on sitagliptin as a third line agent in combination with other antidiabetic agents is still lacking. This study evaluated the safety and efficacy of sitagliptin as an add-on therapyin
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    20
    References
    0
    Citations
    NaN
    KQI
    []